Famotidine Tablet, Film Coated
Product Images NDC 60760-736

2 FDA label images from St. Mary's Medical Park Pharmacy · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 60760-736). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5a3e9c70 B8f8 4866 B128 9f50272c03c0 01)

Image (5a3e9c70 B8f8 4866 B128 9f50272c03c0 01)
Chemical structure of famotidine, showing its molecular components and arrangement including a thiazole ring and functional groups characteristic of this H2 receptor antagonist drug.*
FDA Label Image

736 (Famotidine 736 07)

736 (Famotidine 736 07)
Famotidine 40 mg tablets, USP film-coated, packaged in quantities of 7. The label shows the product name, strength, form, and NDC 60760-736-07. Manufactured by Cadila Healthcare Ltd, Ahmedabad, India, and packaged by St. Mary's Medical Park Pharmacy, Oro Valley, AZ. Directions indicate to use as directed and store at controlled room temperature (15-30°C).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.